RadNet Gross Profit 2010-2024 | RDNT

RadNet gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
RadNet Annual Gross Profit
(Millions of US $)
2023 $221
2022 $166
2021 $192
2020 $106
2019 $154
2018 $108
2017 $120
2016 $109
2015 $101
2014 $115
2013 $104
2012 $104
2011 $107
2010 $98
2009 $130
RadNet Quarterly Gross Profit
(Millions of US $)
2024-09-30 $69
2024-06-30 $70
2024-03-31 $44
2023-12-31 $64
2023-09-30 $60
2023-06-30 $59
2023-03-31 $39
2022-12-31 $54
2022-09-30 $36
2022-06-30 $49
2022-03-31 $27
2021-12-31 $48
2021-09-30 $60
2021-06-30 $50
2021-03-31 $33
2020-12-31 $50
2020-09-30 $45
2020-06-30 $-4
2020-03-31 $14
2019-12-31 $45
2019-09-30 $38
2019-06-30 $43
2019-03-31 $28
2018-12-31 $24
2018-09-30 $34
2018-06-30 $34
2018-03-31 $16
2017-12-31 $35
2017-09-30 $29
2017-06-30 $31
2017-03-31 $24
2016-12-31 $33
2016-09-30 $32
2016-06-30 $25
2016-03-31 $20
2015-12-31 $28
2015-09-30 $33
2015-06-30 $28
2015-03-31 $12
2014-12-31 $29
2014-09-30 $31
2014-06-30 $31
2014-03-31 $24
2013-12-31 $30
2013-09-30 $23
2013-06-30 $28
2013-03-31 $23
2012-12-31 $22
2012-09-30 $27
2012-06-30 $29
2012-03-31 $27
2011-12-31 $25
2011-09-30 $25
2011-06-30 $29
2011-03-31 $28
2010-12-31 $6
2010-09-30 $33
2010-06-30 $33
2010-03-31 $26
2009-12-31 $36
2009-09-30 $31
2009-06-30 $31
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.972B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.703B 0.00
Quest Diagnostics (DGX) United States $17.349B 17.58
DaVita (DVA) United States $14.249B 18.43
Encompass Health (EHC) United States $9.629B 22.70
Chemed (CHE) United States $8.394B 25.80
Elanco Animal Health (ELAN) United States $6.076B 14.46
Option Care Health (OPCH) United States $5.267B 24.96
LifeStance Health (LFST) United States $3.092B 0.00
Amedisys (AMED) United States $3.023B 21.51
Addus HomeCare (ADUS) United States $2.290B 26.87
Astrana Health (ASTH) United States $2.076B 28.39
U.S Physical Therapy (USPH) United States $1.337B 35.14
Pennant (PNTG) United States $0.945B 38.21
Aveanna Healthcare Holdings (AVAH) United States $0.945B 0.00
Atai Life Sciences (ATAI) Germany $0.252B 0.00
Bioqual (BIOQ) United States $0.055B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00